Nystatin (Oral Suspension)
Brand names: Nystan
Nystatin oral suspension is a topical (non-absorbed) polyene antifungal used to treat and prevent candidal infection of the mouth and oropharynx, such as oral thrush.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Nystatin binds to ergosterol in the fungal cell membrane, creating pores that disrupt membrane integrity and cause leakage of intracellular contents and fungal cell death.
Prescribing in practice
- It acts only on contact within the gastrointestinal tract and is negligibly absorbed, so it is effective for local oral and gut candidiasis but not for systemic fungal infection.
- The suspension should be retained in the mouth in contact with the affected areas before swallowing, and treatment continued for a short period after symptoms resolve to prevent relapse.
- It is generally very well tolerated, with occasional gastrointestinal upset or local irritation at higher doses.
Monitoring
Routine monitoring is not required; review response and consider an alternative or investigation for predisposing factors if the infection fails to clear.
Counselling the patient
- Hold the liquid in your mouth, swishing it around the affected areas, before swallowing.
- Keep taking it for a few days after the soreness clears to stop the infection coming back.
- If you wear dentures, clean them well as they can harbour the infection.
Evidence & guidelines
Topical antifungals such as nystatin are an established treatment for oropharyngeal candidiasis, with persistent or recurrent infection prompting a search for underlying causes.
Reference: PHE Guidelines on Candidiasis; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021